Bilateral long bone sclerosis: Erdheim-Chester disease. Case report
Article Sidebar
Main Article Content
Abstract
Erdheim - Chester disease (ECD) is a rare disease, characterized by systemic xanthogranulomatous infiltration, with involvement of various organs including bone. ECD is described within the sclerosing bone disorders, which are recognized for presenting increased bone mass and involvement of both long and flat bones. The clinical presentation of ECD is diverse, ranging from an asymptomatic course to multisystemic manifestations. Radiological features are of great importance to establish the diagnosis.
We describe here a patient with ECD, with bilateral sclerosis of long bones that presents some differential characteristics in relation to other reported cases: a) exclusively bone involvement at 10 years of evolution, b) bilateral and symmetric involvement of different magnitude, c) endosteal and periosteal cortical sclerosis d) radiological signs suggestive of periostitis, d) absence of metaphyseal involvement, e) absence of metabolic activity of the lesions in 18F-FDG PET/CT.
Conclusion: the presence of bilateral osteosclerosis exclusively in long bones should lead to suspect ECD. The absence of metaphyseal involvement and metabolic activity in 18F-FDG PET/CT have been rarely described.
Article Details
Derechos de autor: Actualizaciones en Osteología es la revista oficial de la Asociación Argentina de Osteología y Metabolismo Mineral (AAOMM) que posee los derechos de autor de todo el material publicado en dicha revista.
References
Bejarano NS, Jaramillo LF, Duque MQ y cols. Enfermedades osteocondensantes con compromiso de huesos largos: presentación de dos casos y revisión de la literatura. Rev Colomb Reumatol. 2011;18(3):234-46.
Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672-81.
Goyal G, Heaney ML, Collin M, et al. Erdheim-Chester disease: Consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020;135(22):1929-45.
Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet. 1987;1:208-9.
Ota M, Sakamoto M, Sato K, et al. Immunopathological analysis of Erdheim-Chester disease with massive ascites. Intern Med. 2012;51(19):2825-30.
Haroche J, Charlotte F, Arnaud L, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120(13):2700-3.
Sánchez JE, Mora C, MacIa M, Navarro JF. Erdheim-Chester disease as cause of end-stage renal failure: A case report and review of the literature. Int Urol Nephrol. 2010;42(4):1107-12.
Mazor RD, Manevich-Mazor M, Shoenfeld Y. Erdheim-Chester Disease: A comprehensive review of the literature. Orphanet J Rare Dis. 2013;8(1):137.
Veyssier-Belot C, Cacoub P, Caparros Lefebvre D, et al. Erdheim-Chester Disease: clinical and radiologic characteristics of 59 cases. Medicine (Baltimore). 1996;75(3):157-69.
Arnaud L, Hervier B, Néel A, et al. CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: A multicenter survival analysis of 53 patients. Blood. 2011;117(10):2778-82.
Haroche J, Amoura Z, Dion E, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: Report of 6 new cases and a literature review. Medicine (Baltimore). 2004;83(6):371-92.
Dion E, Graef C, Miquel A, et al. Bone involvement in Erdheim-Chester disease: Imaging findings including periostitis and partial epiphyseal involvement. Radiology. 2006;238(2):632-9.
Boralevi F, Leaute-Labreze C, Tison F, et al. Langerhans-cell histiocytosis and Erdheim-Chester disease: probably not a fortuitous association. Ann Dermatol Venereol. 1998;125:335-8.
Gómez C, Diard F, Chateil JF, Moinard M, Dousset V RJ. Imagerie de la maladie d’Erdheim-Chester. J Radiol. 1996;77(12):1213-21.
Klieger MR, Schultz E, Elkowitz DE, Arlen M, Hajdu SI. Erdheim-Chester disease: A unique presentation with multiple osteolytic lesions of the spine and pelvis that spared the appendicular skeleton. Am J Roentgenol. 2002;178(2):429-32.
Dalinka MK, Turner ML, Thompson JJ, Lee RE. Lipid granulomatosis of the ribs: Focal Erdheim-Chester disease. Radiology. 1982;142(2):297-9.
Abeykoon J, Ravindran A, Rech KL, et al. Mimics of Erdheim-Chester disease. Brit J Haematol. 2022;196:984-94.
Tran TA, Pariente D, Lecron JC, Delwail A, Taoufik Y, Meinzer U. Treatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugs. Arthritis Rheum. 2011;63(12):4031-2.
Oweity T, Scheithauer BW, Hin SC, Lei CMC, Koh PW. Multiple system Erdheim-Chester disease with massive hypothalamic-sellar involvement and hypopituitarism: Case report and review of the literature. J Neurosurg. 2002;96(2):344-51.
Reibaldi A, Sager L, Calvo R y cols. Enfermedad de Erdheim-Chester. Serie de diecinueve casos y un diagnóstico diferencial de relevancia. Rev Argent Reum. 2020;31(2):31-6.
Arnaud L, Malek Z, Archambaud F, Kas A, Toledano D, Drier A, et al. 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in follow-up than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum. 2009;60(10):3128-38.
Juanós Iborra M, Selva-O’Callaghan A, Solanich Moreno J, et al. Erdheim-Chester disease: Study of 12 cases. Med Clin (Barc). 2012;139(9):398-403.
Eyigör S, Kirazli Y, Memis A, Başdemir G. Erdheim-Chester disease: The effect of bisphosphonate treatment - A case report. Arch Phys Med Rehabil. 2005;86(5):1053-7.
Haroche J, Cohen-Aubart F, Emile JF, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood. 2013;121(9):1495-500.
Roodman DG, Guise T. Mechanisms of osteolytic and osteoblastic skeletal lesions. Primer 9 edition: 739-42.
Giuliani N, Rizzoli V, Roodman GD. Multiple myeloma bone disease pathophysiology of osteoblast inhibition. Blood. 2006;108(13):3992-6
Song-Chang Lin, Li-Yuan Yu-Lee, and Sue-Hwa Lin. Osteoblastic factors in prostate cancer metastasis. Current Osteoporosis Rep. 2018;16:642– 7.
Namwongprom S, Nuñez R, Kim EE, Macapinlac HA. Tc-99m MDP Bone Scintigraphy and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Erdheim-Chester Disease. Clin Nucl Med. 2007;32: 35-8.
He T, Cui L, Niu N, et al. Bone mineral density and bone microarchitecture in a cohort of patients with Erdheim-Chester Disease. Orphanet J Rare Dis. 2020;15:236.